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An important question in the alcoholism treatment field is how research findings can be 
translated into real-world clinical practice. Researchers have developed a new 
research–practice integration (RPI) model that can both drive the formulation of studies and 
new research questions and promote improvements in treatment quality. The hallmark of this 
model is a collaborative relationship between the key stakeholders in both alcohol and other 
drug (AOD) treatment and research, including health plan administrators and clinicians, 
treatment program administrators, psychiatry and primary care departments, patients and 
their families, purchasers, and researchers. The issue of technology transfer is especially 
relevant in the realm of adolescent AOD treatment. The implementation and feasibility of the 
RPI model are illustrated by a case study of a managed health care plan’s treatment services 
for adolescents with AOD dependence. In this setting, key research findings are being used to 
shape the plan’s adolescent health services. KEY WORDS: health services research; health care 
delivery; AOD (alcohol and other drug) use; AODD (AOD disorder) care provider; adolescent 
drinking; dual diagnosis; alcoholism treatment services research; treatment program; research in 
practice; research–practice integration (RPI) model; information transfer from research to 
practice; technology transfer; evidence-based practices; intervention 
Translating research findings into clinical practice is a central aspect of current medical science and a 
primary focus of health services research. 
A commonly used term in this context 
is “research to practice,” which refers to 
the process of developing appropriate 
research questions, disseminating the 
results of such research, and applying 
those findings to clinical practice. Over 
the past decade, investigators and clini-
cians have put much effort into fostering 
an environment conducive to vigorous 
technology transfer. In spite of these 
efforts, however, there is continuing 
concern in the alcohol and other drug 
(AOD) treatment fields that much of 
the growing knowledge of effective 
treatment is not finding its way into 
clinical practice. This article provides 
an overview of an innovative, bidirec-
tional “research–practice integration” 
(RPI) process and describes an RPI 
model relevant to the alcohol field. 
The need for RPI particularly in 
programs that treat adolescents with 
alcohol use disorders is addressed, and 
a case study illustrates how the RPI 
model is applied to alcoholism treat-
ment for adolescents in a managed 
care organization. 
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Research–Practice 
Integration 
The literature on health care technology 
transfer suggests that a complex set of 
factors can shape the relationship between 
research and clinical practice. Numerous 
stakeholders are involved with AOD 
treatment, such as health plan adminis­
trators, addiction medicine policymak­
ers, AOD program administrators and 
clinicians, primary care and psychiatric 
health care providers, consumers (i.e., 
patients), and health plan purchasers 
(e.g., employers). Factors influencing 
RPI that are related to these various 
stakeholders include financing issues, 
organizational culture and attitudes, 
and lack of infrastructure or expertise. 
Other factors impacting RPI that may 
act as barriers to the adoption of new 
practices based on research findings are 
more specific to the AOD field. These 
factors include the stigma associated 
with AOD use disorders, diverse schools 
of thought within the treatment com­
munity regarding the most appropriate 
treatment approaches, clinical attitudes, 
and the unique role of the consumer 
in the clinical relationship (Backer et 
al. 1995). 
To address these diverse factors, 
eliminate potential barriers, and thereby 
enhance RPI, many policymakers and 
funding organizations have made the 
dissemination of research findings and 
the adoption and utilization of proven 
treatment technologies a high priority. 
The National Institute on Alcohol Abuse 
and Alcoholism (NIAAA), the National 
Institute on Drug Abuse (NIDA), and 
the Center for Substance Abuse Treatment 
(CSAT) within the Substance Abuse 
and Mental Health Administration 
(SAMHSA), as well as private founda­
tions such as the Robert Wood Johnson 
Foundation, have each sponsored 
efforts to accelerate this process. These 
efforts include the Research to Practice 
Forums, the Researcher in Residence 
program, the Connecting Services and 
Research (CSR) system, the Addiction 
Technology Transfer Centers (ATTCs), 
and various conferences and community 
symposia (U.S. Department of Health 
and Human Services 2000). 
Researchers increasingly are examining 
deficits in the traditional approach to 
dissemination of research findings, which 
involves publishing articles in the scien­
tific literature and making presentations 
at conferences and symposia (Brown 
2000). Other investigators have suggested 
conceptual models (Simpson 2002) and 
strategies for facilitating the transfer of 
new treatment technologies (ATTC 
Network 2004; Brown 2003), which 
have resulted in significant insights: 
•	 Backer (1995) determined that 
organizational readiness for change 
is a crucial prerequisite for successful 
technology transfer. 
•	 Sorensen and Clark (1995) described 
a successful technology transfer strategy 
that explicitly integrated dissemina­
tion activities into a research program. 
•	 The ATTC National Office devel­
oped a practical, step-by-step guide 
to technology transfer activities 
called The Change Book (ATTC 
Network 2004; Brown 2003). 
Despite such efforts to increase the 
adoption of new treatments, however, 
research findings related to AOD treat­
ment still are clearly underutilized. 
With few exceptions, no clinical guide­
lines have been developed in addiction 
medicine and AOD treatment, or have 
achieved the same level of acceptance as 
similar guidelines in other medical spe­
cialty areas. Moreover, interventions 
that have been shown to be effective in 
treating AOD use disorders and other 
addictions have not been widely adopted. 
A Novel RPI Model 
Researchers from Kaiser Permanente 
Northern California and the University 
of California San Francisco recently 
developed a collaborative RPI model 
that is based on published findings, 
organizational theory, and an under­
standing of how health plans work. 
This model draws both on experience 
in the AOD field (Backer et al. 1986; 
Brown 2003; Petry 2000; Sorensen and 
Clark 1995) and on the larger technology 
transfer literature, incorporating concepts 
such as social marketing, readiness for 
change, planned versus responsive and 
reactive health promotion, and theories 
of technology diffusion (Backer 1995; 
Lehman et al. 2002; Lomas 1993; 
Sobell 1996). The hallmark of this 
model is a bidirectional relationship 
between the key stakeholders in both 
AOD treatment and research (e.g., 
patients, clinicians, managers, policy-
makers, and researchers) (see the fig­
ure). Depending on the expertise and 
resources needed, different stakeholder 
groups take the lead at different stages 
in the research and RPI process. Thus, 
the model assumes continuous interac­
tion between the various stakeholder 
groups, and feedback from them, both 
in developing research questions and in 
adopting findings to clinical practice. 
The ultimate goals are to improve clini­
cal practice, including better patient 
outcomes, and to generate research 
questions for further study. 
This model is circular and the various 
stages can be repeated several times. To 
illustrate the process, one can begin with 
the development of research questions. 
Clinically relevant research questions 
can be derived from many different 
sources, such as: 
•	 Findings from earlier studies 
(e.g., on the proven efficacy of new 
treatments). 
•	 Clinical concerns (e.g., the presence 
of co-occurring disorders in AOD 
patients or the rapid rise in the 
abuse of certain pain medications). 
•	 Changing cultural attitudes (e.g., less­
ening of sanctions for marijuana use). 
•	 Policy agendas (e.g., efforts by 
health plans to comply with legisla­
tion to ensure that AOD treatment 
receives the same insurance coverage 
as treatment for other medical con­
ditions [i.e., parity]). 
To develop research questions that 
are relevant to clinical practice, researchers 
must work closely with AOD clinicians 
and program managers and with policy-
makers in the larger organization. New 
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clinical concerns can emerge at any 
point—for example, when new evidence-
based technologies are developed and 
must be adapted to real-world settings, 
or when new client characteristics are 
identified that raise important clinical 
questions. Researchers can use these 
concerns to formulate testable research 
questions that can lead to generalizable 
results and to develop appropriate 
treatment interventions for study, 
drawing also upon the literature in 
other related fields, earlier findings, 
and scientific expertise. 
Once research questions have been 
generated and/or an intervention devel­
oped that takes the concerns of the 
various stakeholder groups into consid­
eration, investigators can design and 
conduct a study of the effectiveness of 
this intervention. If the approach studied 
proves effective (or an epidemiological 
study provides new information on 
client populations that helps determine 
treatment needs), appropriate changes 
in treatment programs should be 
implemented. As with the initial devel­
opment of the intervention, the input 
of key stakeholders in shaping program 
services is critical. During the imple­
mentation process it is important to 
maintain the integrity of the original 
intervention studied while ensuring its 
feasibility and acceptability in real-world 
treatment programs. 
To ensure that treatment programs 
will adopt and continue to implement 
new services and interventions, research 
staff must work closely with the pro­
grams to provide training and technical 
assistance until the program management 
and staff feel comfortable and proficient 
with the new approach. Subsequently, 
the groups should continue to meet 
regularly to discuss the ongoing progress 
of the new services and ensure the suc­
cessful adoption of the new technology. 
Finally, feedback from the various 
stakeholders regarding the overall impact 
of a particular intervention or policy 
should be continuously incorporated into 
the development of new research ques­
tions, beginning the cycle of RPI anew. 
Factors Influencing the 
RPI Model 
Central steps in RPI activities in any 
health care organization are to: 
•	 Identify key decisionmakers and 
other stakeholders (e.g., health plan 
administrators, policymakers, AOD 
program administrators, clinicians, 
mental health and primary care 
providers, patients, and health plan 
purchasers). 
•	 Delineate the interests and concerns 
of these stakeholders. 
•	 Create potential strategies for address­
ing these interests and concerns. 
As new research questions are gener­
ated and RPI activities evolve, the types 
of stakeholders involved and their rela­
tive influence on the process may shift. 
Moreover, these stakeholder groups will 
differ across various types of institutions, 
such as juvenile justice, welfare agencies, 
and schools. The following discussion 
focuses on the influence of stakeholder 
perspectives in the context of a health 
plan; different sets of factors may 
become relevant in other settings. 
Organizational Factors  
RPI efforts to change AOD treatment 
practices in health care organizations 
can face significant challenges related 
to the organization’s administrative 
infrastructure. These challenges may 
include competing disease priorities, 
A model of research–practice integration. 
* Stakeholders include: consumers, program administrators, researchers, primary care and psychiatry providers, AOD clinicians, purchasers/employers, health plan 
regional/national leadership, and accreditation bodies (e.g., National Committee for Quality Assurance). 
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financial concerns, infrastructure prob­
lems, and data collection that is not 
standardized across programs. For example, 
health care organizations may spend 
fewer organizational resources on AOD 
problems than on disorders such as car­
diovascular disease or diabetes. Further­
more, fierce competition in the health 
care marketplace can result in financial 
obstacles to the adoption of new technolo­
gies, particularly in relation to disorders 
that receive less attention than others, 
such as AOD disorders. In addition, 
health care organizations often lack 
the management information systems 
infrastructure necessary to collect and 
manage research-quality data, and most 
U.S. AOD programs do not standard­
ize their data collection. 
To address these challenges, the RPI 
model presented here is centered on 
collaboration among researchers, clini­
cians, and organizational decisionmakers 
(e.g., best practices groups or groups of 
medical department chiefs). According 
to this model, researchers can provide 
data on problem prevalence, services 
utilization, and cost impacts. Clinicians 
then can use this information to increase 
organizational decisionmakers’ aware­
ness of the significance and burden of 
AOD problems, encourage the organi­
zation’s support of treatment approaches 
that are informed by research, and 
make a “business case” on how provid­
ing high-quality, evidenced-based 
AOD treatment is valuable to the orga­
nization. Researchers also can provide 
technical assistance to the organization 
to facilitate standardization of data col­
lection and management instruments 
and generate capacities to gather high-
quality patient- and program-level data 
for future research and program evalua­
tion. 
Program Factors 
Concerns about resources—such as staff 
time, space, and information technology 
capacity—may impede the adoption of 
new interventions and technologies in 
individual treatment programs. Mistrust 
of or unfamiliarity with the research 
process, as well as lack of enthusiastic, 
visible leadership support for studies, 
also can hinder the RPI process. Accord­
ingly, researchers must work closely 
with program administrators to promote 
structural changes that allow new treat­
ment approaches to be studied and 
implemented. For example, many of 
the current evidence-based interventions 
rely on one-to-one interactions between 
therapist and patient rather than the 
group-based therapies predominantly 
used in AOD treatment programs. There­
fore, adopting one-on-one approaches 
may be more complex than simply 
beginning to offer the intervention and 
may require major restructuring of pro­
grams and possibly an enhancement of 
staff skills in general. Some programs 
also may have contracts with purchasers 
or behavioral health firms to provide a 
particular standard or model of care, 
preventing the introduction of new 
approaches. Finally, some new inter­
ventions (e.g., harm reduction models 
or medications) can pose challenges to 
long-held beliefs regarding appropriate 
treatment approaches. 
Research teams must maintain ongo­
ing contact with program leadership to 
encourage active support of research 
activities, thereby facilitating a “research­
friendly” environment in the program. 
Only in such an environment is it pos­
sible to optimize adoption of new suc­
cessful interventions, study adaptations 
of evidence-based approaches, and 
develop new “next-step” research ques­
tions. Researchers also must interact 
with program managers to thoroughly 
assess the financial impact of any new 
treatment approach and to identify and 
target resource barriers. 
Clinical Factors 
Clinicians involved in AOD treatment 
represent perhaps the most crucial 
stakeholder group in the RPI model 
presented here. Consequently, most 
RPI activities traditionally have taken 
place at the clinical level in the form of 
treatment manuals and training. At the 
same time, some of the obstacles to 
knowledge transfer and utilization are 
directly related to the role of clinicians. 
These obstacles include time constraints, 
ideological differences on the best treat­
ment approaches, lack of familiarity 
with the research process, failure of 
traditional modes of information dis­
semination, and differences in the data 
needs of clinicians. To help address these 
obstacles, researchers must be especially 
careful to involve AOD clinicians in 
the research process, rather than just 
presenting them with a new intervention. 
By addressing long-held concerns about 
certain treatment approaches (e.g., use 
of medications) and developing research 
study designs that take into account 
the context within which new inter­
ventions will take place, researchers 
enhance not only the feasibility of the 
study but also the likelihood that the 
findings will later be adopted. 
In the RPI model presented here, 
researchers work with clinical interest 
groups, reporting findings and soliciting 
clinician expertise on the interpretation 
of study results and the development of 
further relevant research questions. The 
technology transfer literature suggests 
that traditional means of dissemination— 
through academic journals and confer­
ences—may be ineffective with clini­
cians (Lamb et al. 1998). Accordingly, 
this RPI model proposes that research 
teams instead use a variety of strategies 
and media to share findings from research 
studies with clinicians and thus involve 
them in the research enterprise. These 
strategies could include interactive 
small-group seminars and training ses­
sions, teleconferencing, and user-friendly 
clinical tools, such as screening instru­
ments and client educational materials 
that use key, understandable statistics. 
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Patient Factors 
The AOD treatment community has 
lagged behind other areas of medicine 
with respect to understanding the role 
of patients in influencing treatment 
approaches. Historically, AOD patients 
and their families rarely have been 
involved in advocating the development 
of new therapies or in shaping the 
treatments available to them. The RPI 
model described here facilitates patients’ 
understanding of available treatments 
and research opportunities, thereby 
helping to develop the “consumer” status 
that patients now enjoy in other areas 
of health care—including the ability to 
effectively seek out and demand evidence-
based treatments (Institute of Medicine 
2001, 2005). 
From the patients’ perspective, a 
critical barrier to the transfer of research 
findings into clinical practice is the 
overwhelming stigma associated with 
AOD use disorders. Negative attitudes 
toward AOD patients from society at 
large, from treatment providers, and 
from patients themselves can make it 
almost impossible for patients to assume 
the role of health care consumers 
empowered to demand the highest 
quality evidence-based treatment (Link 
et al. 1999). Effective dissemination of 
research findings and assistance with 
the interpretation of these findings 
offer the best answers to this challenge. 
Accordingly, in this RPI model the 
research teams provide patients with 
information from their earlier studies 
and findings from the broader literature 
related to AOD treatment effectiveness 
using media such as newsletters, Web 
sites, and discussion groups. Focus groups 
and interviews also can effectively solicit 
patient concerns and inform future 
research based on the patients’ experi­
ences with AOD problems and existing 
treatment. 
Purchasing-Decision Factors 
Purchasers of health care services include 
employers, unions, and other organiza­
tions that decide which treatments 
should be available to their members. 
Large purchasers frequently are concerned 
about costs and have misperceptions 
about the effectiveness of certain treat­
ment approaches, which have been 
shaped by marketing campaigns. Because 
insurers are responsive to purchaser 
demands, this stakeholder group has 
the power to significantly impact the 
types of benefits health plans provide. 
For example, purchasers may demand 
that health plans limit AOD treatment 
benefits, and/or they may contract out 
AOD services to other providers. 
Conversely, purchasers may insist upon 
more intensive and costly forms of 
treatment, such as inpatient treatment, 
believing that it will prove more effective 
for their employees or members. These 
requests may not be related to what is 
evidence based. AOD program admin­
istrators can use the research findings 
that have been provided to them to 
educate organizational leaders (and 
through them, purchasers) about effec­
tive treatment interventions and to 
promote evidence-based treatment 
interventions. 
Factors Related to Other Health 
Care Providers 
Primary Care Providers. Across most 
health care organizations, primary care 
providers and AOD treatment providers 
generally continue to operate indepen­
dently, with little integration of their 
services, although growing evidence 
suggests that such integration can con­
tribute to better outcomes (Weisner et 
al. 2001; Fleming et al. 1997). This 
lack of integration can lead to missed 
opportunities to intervene with patients 
who could benefit from AOD treatment 
(Bethell et al. 2001; Singer et al. 1987). 
For a variety of reasons—including 
lack of knowledge or discomfort about 
AOD use disorders, inadequate clinical 
tools, time constraints, ignorance of 
treatment resources, and issues of pro­
fessional jurisdiction—many primary 
care providers rarely screen for or discuss 
AOD use with their patients (American 
Academy of Pediatrics 2002). As a result, 
patients at risk for AOD-related prob­
lems may not be identified until they 
exhibit severe symptoms. Researchers 
can address such barriers by working 
with primary care providers to identify 
obstacles to screening and treatment, to 
develop user-friendly instruments that 
physicians consider realistic and feasible 
for use in busy medical settings, and to 
study the organizational/structural bar­
riers to screening. According to the RPI 
model presented here, researchers should 
actively solicit the input of primary 
care providers on a variety of research 
activities ranging from research ques­
tions to dissemination strategies. Such 
discussions can enhance the relation­
ships between primary care providers 
and AOD treatment clinicians on the 
one hand and primary care providers 
and researchers on the other, as well as 
provide a forum in which physicians 
can suggest questions for further study. 
Psychiatric Care Providers. Many patients 
receiving AOD treatment have mental 
health problems; conversely, many 
patients with mental health problems 
have AOD problems (Escobedo et al. 
1998; Grella et al. 2001; Hser et al. 
2001; Morrison et al. 1993; Rao et al. 
2000). In fact, the concept of “dual dis­
orders” has become nearly ubiquitous 
in both the AOD and psychiatry fields. 
Although the AOD and psychiatry 
fields have closer disciplinary ties to 
each other than to the primary care 
field, they have exhibited less than 
optimal collaboration in the past—a 
state of affairs that often continues to 
this day (SAMHSA 2002; Institute of 
Medicine 2005). 
Mental health clinicians’ beliefs, 
training, and behaviors regarding AOD 
use can constitute important barriers to 
the effective treatment of patients with 
AOD-related problems. Historically, 
mental health providers have not rou­
tinely assessed patients for AOD prob­
lems (and by the same token, AOD 
treatment providers have not systemati­
cally screened their patients for mental 
health problems). In addition, ideologi­
cal differences between the mental 
health and alcohol fields sometimes 
have created barriers to effective assess­
ment, referral, and treatment of mental 
health patients with AOD problems. 
To facilitate new interventions, 
researchers must actively seek to involve 
mental health clinicians and adminis­
trators in the RPI process for AOD 
treatment. Clinical mental health opinion 
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leaders can drive the process of knowl­
edge utilization. As with primary care 
providers, researchers should solicit the 
input of these opinion leaders on the 
development of research questions 
relevant to their clinical interests, on 
strategies for successfully implementing 
evidence-based practices featuring psy­
chiatric components, and on studies of 
the effectiveness of integrated treatment 
approaches. Researchers also should 
facilitate the information exchange 
between AOD researchers and clinicians 
on the one hand and psychiatric clini­
cians on the other hand by organizing 
opportunities for multidisciplinary 
communication and education. 
Research–Practice 
Integration in AOD 
Treatment of Adolescents 
The RPI model can be particularly 
important in the area of AOD treat­
ment of adolescents, because RPI has 
been less well studied in this area, and 
fewer proven, evidence-based interven­
tions are available for this population. 
In this case, the RPI model builds on 
the adolescent treatment literature but 
also relies on clinicians, patients, and 
parents to help guide the development 
of research questions and interventions 
to be tested. 
An increasing number of studies 
have demonstrated that treatment can 
be effective for adolescents with AOD-
related problems (Booth and Kwiatkowski 
1999; Catalano et al. 1990–91; Deas 
and Thomas 2001; Jainchill 2000). 
Treatment in a variety of settings (e.g., 
inpatient, residential, and outpatient) 
and using various modalities (e.g., 12­
step, family systems, and cognitive-
behavioral therapy) has been found to 
reduce both AOD use and problems in 
other domains (e.g., mental health, 
educational, and legal problems) 
(Grella et al. 2001; Hser et al. 2001; 
Waldron and Kaminer 2004). 
Most adolescents who seek AOD 
treatment also have problems in other 
areas of their lives. For example, many 
teenagers in AOD treatment also suffer 
from mental health problems and/or 
have experienced family conflicts as 
well as educational and legal problems. 
Similarly, experimentation with AODs 
is relatively common among adolescents, 
and most of them do not develop 
AOD abuse or dependence. Accordingly, 
the assessment, diagnosis, and treat­
ment of AOD-related problems can be 
more difficult in adolescents than in 
adults. Furthermore, because adolescent 
AOD use so often is entangled with 
other problems, a flexible, integrated 
approach to treatment is especially 
appropriate with this population. For 
these reasons, researchers have tested 
the application of the RPI model to 
AOD treatment of adolescents. The 
following section presents the findings 
of one case study. 
Case Study of the Application of the 
RPI Model in AOD Treatment of 
Adolescents 
A study by Sterling and colleagues 
(2004) applied the RPI model to AOD 
treatment services for adolescents in a 
managed health care plan. These 
researchers examined pathways to treat­
ment, the demographic and epidemio­
logical characteristics of the adolescents 
entering treatment, and the factors 
associated with treatment retention and 
outcome. The treatment programs 
studied were representative of common 
AOD treatment approaches for adoles­
cents in the United States, which typi­
cally are abstinence based, intensive, 
structured, and provided on an outpa­
tient basis (Jainchill 2000). (For more 
information on the sample, program 
sites, and methodology of the study, see 
Sterling et al. 2004.) The study involved 
the participation of all stakeholders 
outlined in the RPI model. 
This study was initiated by the health 
plan’s adolescent AOD treatment clini­
cians, who expressed concerns that 
patients delayed entering treatment 
until their problems (including mental 
health problems) had become severe. 
The clinicians also were interested in 
examining which patients had better 
outcomes and which treatment factors 
were related to improvement. To ensure 
a positive experience for the participating 
programs and to optimize the relevance 
of study findings, the researchers worked 
with clinicians and program adminis­
trators to identify relevant research 
questions, develop study instruments 
also appropriate for clinical practice, 
and design study protocols that would 
minimally disrupt clinic operations. 
AOD treatment providers and admin­
istrators (as well as adolescent patients 
and their parents) also participated in 
extensive qualitative interviews and 
focus groups that provided background 
information for understanding the study 
findings and informed subsequent fol­
lowup data collection. 
As epidemiological data and outcome 
results from the study have become 
available, researchers have regularly pre­
sented the results to program staff and 
solicited their opinions on the implica­
tions of these findings for treatment 
services and coordination. 
Key findings that have emerged from 
this study to date include the following: 
•	 Compared with matched control 
subjects, adolescents entering AOD 
treatment had significantly higher 
rates of several psychiatric and med­
ical conditions (Sterling et al. 2004). 
They also had more legal, educa­
tional, and familial problems. 
•	 Adolescents entering treatment 
reported high levels of AOD con­
sumption as well as AOD abuse and 
dependence symptoms, which could 
confirm clinicians’ suggestions that 
these patients were delaying treat­
ment entry until their problems 
became severe (Sterling et al. 2004). 
•	 Significant variability existed in 
the pathways through which these 
patients entered treatment (Sterling 
et al. 2004). For example, boys were 
more likely than girls to have been 
referred to treatment from the legal 
system. Only a relatively small pro­
portion of the sample had been 
referred by one of their health plan’s 
medical or psychiatric providers. 
•	 Girls were significantly more likely 
than boys to have received previous 
mental health treatment (Sterling et 
al. 2004). 
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•	 Integrated services—such as con­
comitant AOD and psychiatric 
treatment and delivery of various 
other services in a single location, 
also referred to as “one-stop shop­
ping”—improved AOD outcomes 
(Sterling and Weisner 2005).  
Taken together, these findings sug­
gest that adolescents entering AOD 
treatment have serious problems across 
several different life domains and that 
health plan departments likely to deal 
with these adolescents (i.e., AOD treat­
ment, primary care, and psychiatry 
departments) could more effectively 
identify and refer “at risk” patients for 
treatment. Moreover, structural and 
clinical changes that increase integra­
tion between the involved departments, 
particularly between the AOD pro­
grams and the psychiatry department, 
could improve outcomes significantly . 
The results obtained by Sterling and 
colleagues (2004) have been used in 
turn to alter the health plan’s practices 
for AOD treatment of adolescents in 
various ways: 
•	 The researchers participating in the 
study worked closely with the health 
plan’s program administrators and 
regional leadership groups (e.g., best 
practices committees and departmen­
tal chiefs groups) to develop pro­
grams and policies that can improve 
interdepartmental integration. For 
example, findings from this and 
related studies helped the health 
plan’s Dual Diagnosis Best Practices 
Committee to implement a “liaison” 
initiative, which places a clinician 
specially trained in dual diagnoses in 
each AOD treatment and psychiatry 
clinic to act as a resource for profes­
sional staff in these clinics. Similarly, 
findings from this and other studies 
have been used at liaison training 
sessions on co-occurring disorders 
and integrated treatment. 
•	 The Dual Diagnosis Best Practices 
Committee also used the study’s 
prevalence data on comorbidity 
when discussing resource allocation 
with the health plan’s leadership, 
emphasizing the value of providing 
high-quality services for patients 
with co-occurring conditions. 
•	 The researchers also are continuing 
to work with other health plan lead­
ership groups (e.g., pediatric chiefs, 
pediatric psychiatry chiefs, adoles­
cent AOD treatment coordinating 
chiefs) to influence adolescent 
health care policy and practices in 
the organization (e.g., developing a 
study that will survey primary care 
providers to identify barriers to 
screening and referral of adolescents 
with AOD problems). 
Over the course of this interaction 
between the researchers and the various 
stakeholder groups, the stakeholders 
have become effective clinical partners, 
suggesting additional research ques­
tions that are relevant to their clinical 
work and the larger field. 
Conclusions 
Approaches to integrating research and 
practice have changed in the past few 
years in two important ways. First, most 
traditional RPI models have focused on 
a unidirectional process of information 
dissemination—that is, from research 
to the clinical setting—on the assump­
tion that research questions were devel­
oped by the researchers and the results 
then flowed down to practice. The case 
example presented here, however, demon­
strates the synergy that can develop 
when clinicians and other stakeholders 
are brought into the process of devel­
oping research questions that can either 
be new or serve as “next steps” in a 
clinic’s development of evidence-based 
interventions. 
Second, the traditional RPI process 
has not involved multiple stakeholders 
and has focused primarily on conven­
tional forms of technology transfer 
(i.e., publishing articles and manuals 
and providing training). In contrast, 
this model illustrates the importance 
of considering the wide range of stake­
holders involved. Thus, the recent 
experience of health services researchers 
has highlighted the importance of a 
two-way RPI model that, in addition 
to the research perspective, incorporates 
knowledge of organizations, financing, 
and program characteristics, as well as 
clinician, patient, and environmental 
factors, using a variety of technology 
transfer approaches. 
The case study presented here was 
based on the organizational context of 
a health plan; other considerations 
would come into play in other organi­
zational settings, such as criminal jus­
tice, school, or child welfare settings. In 
a school setting, for example, successful 
implementation of an intervention 
based on enhanced screening and refer­
ral of adolescents with AOD problems 
would involve the funding entity of 
the school (e.g., community or private 
organization), the school district, prin­
cipals, teachers, parents, and students. 
Even specialized alcoholism treatment 
programs outside of health plans have 
analogous stakeholders in their fiscal 
components and/or larger umbrella 
organizations that provide funding or 
play other important roles for some of 
these programs. 
The next stages of health services 
research on RPI and adolescent AOD 
treatment should study how stakehold­
ers from different types of agencies 
(e.g., schools, juvenile justice, welfare) 
can be involved. This process should 
identify key strategies that are both 
relevant across different settings and 
unique to particular settings. Furthermore, 
it is important to develop ways to 
communicate research questions raised 
by patients, clinicians, and program 
administrators to researchers. Many 
researchers in academic settings do not 
have the benefit of contact with treat­
ment institutions. Therefore, it will be 
essential to devise ways to link research 
groups with treatment programs that 
have similar interests. 
The development and implementa­
tion of RPI models is an exciting and 
timely area of health services research, 
particularly in the AOD treatment 
field. These models can help identify 
research questions that assist in develop­
ing new interventions or constellations 
of services, adapt them to real-world 
clinical practice, and measure their 
effectiveness.  ■ 
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